Jane Street’s Maravai LifeSciences MRVI Stock Holding History

Jane Street’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79.2K	Sell	12,700 -52,700	-81%	-$228K	﹤0.01%	10724
2026 Q1	$185K	Buy	65,400 +38,300	+141%	+$130K	﹤0.01%	10223
2025 Q4	$88.1K	Sell	27,100 -1,700	-6%	-$5.72K	﹤0.01%	10244
2025 Q3	$82.7K	Hold	28,800	–	–	﹤0.01%	10212
2025 Q2	$69.4K	Buy	+28,800	New	+$60.5K	﹤0.01%	9092
2024 Q2	–	Sell	-13,900	Closed	-$121K	–	9900
2024 Q1	$121K	Buy	+13,900	New	+$94K	﹤0.01%	8456
2022 Q4	–	Sell	-23,200	Closed	-$592K	–	9759
2022 Q3	$592K	Buy	+23,200	New	+$582K	﹤0.01%	6374
2022 Q2	–	Sell	-12,600	Closed	-$444K	–	10433
2022 Q1	$444K	Sell	12,600 -20,700	-62%	-$694K	﹤0.01%	7704
2021 Q4	$1.4M	Sell	33,300 -5,000	-13%	-$203K	﹤0.01%	5239
2021 Q3	$1.88M	Buy	38,300 +24,900	+186%	+$1.21M	﹤0.01%	4600
2021 Q2	$559K	Buy	+13,400	New	+$519K	﹤0.01%	7030

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Jane Street's MRVI Position: Q2 2026 in Review

Jane Street reduced its Maravai LifeSciences (MRVI) stake by 91% in Q2 2026, selling an estimated $6.45M and leaving 142,590 shares worth $890K. The position accounts for ﹤0.01% of the portfolio, ranked #6779.

Jane Street first reported a position in MRVI in Q4 2020 and has held it in 21 quarters since. The position peaked at $4.63M in Q1 2026. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Jane Street held 142,590 shares of Maravai LifeSciences worth $890K as of Q2 2026.
Jane Street sold 1,493,555 Maravai LifeSciences shares in Q2 2026, an estimated $6.45M.
Maravai LifeSciences made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6779 holding.
Jane Street first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 21 quarters since.
Jane Street's Maravai LifeSciences position peaked at $4.63M in Q1 2026.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.